Capital World Investors - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 145 filers reported holding THERAVANCE INC in Q1 2014. The put-call ratio across all filers is 0.93 and the average weighting 0.4%.

Quarter-by-quarter ownership
Capital World Investors ownership history of THERAVANCE INC
ValueSharesWeighting
Q2 2015$23,491,000
+14.9%
1,300,0000.0%0.01%0.0%
Q1 2015$20,436,000
-54.8%
1,300,000
-59.3%
0.01%
-50.0%
Q4 2014$45,238,000
-56.8%
3,197,000
-47.8%
0.01%
-58.6%
Q3 2014$104,621,000
-51.8%
6,121,777
-16.0%
0.03%
-51.7%
Q2 2014$217,123,000
-3.2%
7,290,900
+0.6%
0.06%
-6.2%
Q1 2014$224,343,000
+275.5%
7,250,900
+332.6%
0.06%
+276.5%
Q4 2013$59,747,000
+6.2%
1,675,946
+21.9%
0.02%0.0%
Q3 2013$56,241,000
+62.7%
1,375,414
+53.3%
0.02%
+54.5%
Q2 2013$34,561,000897,0000.01%
Other shareholders
THERAVANCE INC shareholders Q1 2014
NameSharesValueWeighting ↓
Baupost Group 16,538,977$637,247,00015.84%
Litespeed Management, L.L.C. 1,516,994$58,450,00010.69%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,584,469$99,580,0006.38%
Realm Partners LLC 166,061$6,398,0005.30%
IRIDIAN ASSET MANAGEMENT LLC/CT 10,000$385,300,0004.86%
SECTORAL ASSET MANAGEMENT INC 3,167,118$122,029,0003.61%
IRIDIAN ASSET MANAGEMENT LLC/CT 6,004,316$231,346,0002.92%
BB BIOTECH AG 888,244$34,224,0002.46%
Portolan Capital Management 163,617$6,304,0001.80%
Trellus Management Company, LLC 20,000$771,0000.98%
View complete list of THERAVANCE INC shareholders